"Aspirin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
| Descriptor ID |
D001241
|
| MeSH Number(s) |
D02.455.426.559.389.657.410.595.176
|
| Concept/Terms |
Aspirin- Aspirin
- Acetylsalicylic Acid
- Acid, Acetylsalicylic
- 2-(Acetyloxy)benzoic Acid
|
Below are MeSH descriptors whose meaning is more general than "Aspirin".
Below are MeSH descriptors whose meaning is more specific than "Aspirin".
This graph shows the total number of publications written about "Aspirin" by people in this website by year, and whether "Aspirin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 1999 | 1 | 1 | 2 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 4 | 4 |
| 2002 | 1 | 1 | 2 |
| 2003 | 4 | 2 | 6 |
| 2004 | 2 | 2 | 4 |
| 2005 | 2 | 3 | 5 |
| 2006 | 1 | 5 | 6 |
| 2007 | 2 | 1 | 3 |
| 2008 | 2 | 2 | 4 |
| 2009 | 2 | 3 | 5 |
| 2010 | 2 | 1 | 3 |
| 2011 | 3 | 2 | 5 |
| 2012 | 4 | 1 | 5 |
| 2013 | 6 | 0 | 6 |
| 2014 | 1 | 4 | 5 |
| 2015 | 5 | 1 | 6 |
| 2016 | 5 | 1 | 6 |
| 2017 | 6 | 3 | 9 |
| 2018 | 6 | 6 | 12 |
| 2019 | 5 | 1 | 6 |
| 2020 | 6 | 7 | 13 |
| 2021 | 5 | 5 | 10 |
| 2022 | 2 | 5 | 7 |
| 2023 | 1 | 2 | 3 |
| 2024 | 0 | 1 | 1 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aspirin" by people in Profiles.
-
Extended dual antithrombotic therapy in patients with chronic coronary syndrome - which agent should be added to aspirin? Cardiol J. 2025; 32(3):321-327.
-
Practice patterns of antiplatelet and anticoagulant therapy after fenestrated/branched endovascular aortic repair. J Vasc Surg. 2024 Oct; 80(4):968-978.e3.
-
The underutilization of preventive cardiovascular measures in patients with cancer: an analysis of the Behavioural Risk Factor Surveillance System, 2011-22. Eur J Prev Cardiol. 2023 09 20; 30(13):1325-1332.
-
Association of Clinician Practice Ownership With Ability of Primary Care Practices to Improve Quality Without Increasing Burnout. JAMA Health Forum. 2023 03 03; 4(3):e230299.
-
Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility. JAMA Netw Open. 2023 02 01; 6(2):e230666.
-
The effects of heparin, aspirin, and maternal clinical factors on the rate of nonreportable cell-free DNA results: a retrospective cohort study. Am J Obstet Gynecol MFM. 2023 03; 5(3):100846.
-
Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits. J Vasc Surg. 2023 04; 77(4):1107-1118.e2.
-
Low-dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation. Liver Transpl. 2022 12; 28(12):1888-1898.
-
The Cost of Breaking Even: a Perspective on the Net Clinical Impact of Adding Aspirin to Antithrombotic Therapies in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. Cardiovasc Drugs Ther. 2024 Jun; 38(3):605-619.
-
Do We Really Need Aspirin Loading for STEMI? Cardiovasc Drugs Ther. 2022 12; 36(6):1221-1238.